← Back to Search

Remote Blood Pressure Monitoring for High Blood Pressure (REACH Trial)

N/A
Waitlist Available
Led By Courtney Lyles, PhD
Research Sponsored by University of California, San Francisco
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Over the age of 18
Uncontrolled hypertension (HTN) in the HTN registry
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 6 months
Awards & highlights

REACH Trial Summary

This trial will study whether home blood pressure monitors and digital messaging programs can help patients with hypertension manage their condition.

Who is the study for?
This trial is for adults over 18 within the San Francisco Health Network who have uncontrolled high blood pressure and are listed in the hypertension registry. Participants must be able to speak English or Spanish, have seen their primary care provider in the last two years, and either completed Aim 1 training or be willing to do so.Check my eligibility
What is being tested?
The study tests if using home blood pressure monitors along with digital tools like texting, mobile apps, and online medical records can help patients manage their high blood pressure better over a period of one year.See study design
What are the potential side effects?
Since this trial involves non-invasive monitoring and digital communication rather than medication, there are no direct side effects from interventions. However, participants may experience stress or anxiety related to self-monitoring.

REACH Trial Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below
Select...
I am over 18 years old.
Select...
My high blood pressure is not under control.

REACH Trial Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~6 months
This trial's timeline: 3 weeks for screening, Varies for treatment, and 6 months for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Systolic blood pressure (SBP)
Secondary outcome measures
Blood Pressure (BP) control
Change in Home BP
Krousel-Wood Adherence Scale for medication adherence
+2 more

REACH Trial Design

3Treatment groups
Experimental Treatment
Active Control
Group I: Cellular Home blood pressure (BP) monitoring with minimal supportExperimental Treatment1 Intervention
Patients will be instructed to write down their blood pressures (BP) in a BP log that will be provided to them at the time of enrollment. Study staff will access the patient's home BP measurements on the BP device dashboard and send a summary of the home BP measurements (mean, median, % of BP measurements at goal) to the primary care provider in a telephone encounter (TE) 3 to 5 days prior to the next scheduled visit.
Group II: Cellular Home blood pressure (BP) monitoring with pharmacist support for treatment intensificationActive Control1 Intervention
For patients randomized to this intervention arm, a pharmacist will review the home blood pressure (BP) measurements and use an evidence-based algorithm to make recommendations for medication intensification. If the patient has a primary care provider (PCP) appointment within 2 weeks, the pharmacist will send a telephone encounter (TE) with BP measurements and medication recommendations to the PCP 3 -5 days prior to the scheduled appointment. If the patients has no appointment scheduled within two weeks, the pharmacist will call the patient and prescribe medication intensification if the patient is amenable.
Group III: Non-randomized usual careActive Control1 Intervention
To compare the two intervention arms with usual care, investigators will extract electronic health record (EHR) data on active San Francisco Health Network (SFHN) adult patients (age 18+) with diagnosis of hypertension who made at least one primary care visit during the study period.

Find a Location

Who is running the clinical trial?

University of California, San FranciscoLead Sponsor
2,500 Previous Clinical Trials
15,235,931 Total Patients Enrolled
National Heart, Lung, and Blood Institute (NHLBI)NIH
3,833 Previous Clinical Trials
47,305,956 Total Patients Enrolled
Courtney Lyles, PhDPrincipal InvestigatorUniversity of California, San Francisco
2 Previous Clinical Trials
319 Total Patients Enrolled

Media Library

Home Blood Pressure Monitoring Clinical Trial Eligibility Overview. Trial Name: NCT05481892 — N/A
High Blood Pressure Research Study Groups: Cellular Home blood pressure (BP) monitoring with pharmacist support for treatment intensification, Non-randomized usual care, Cellular Home blood pressure (BP) monitoring with minimal support
High Blood Pressure Clinical Trial 2023: Home Blood Pressure Monitoring Highlights & Side Effects. Trial Name: NCT05481892 — N/A
Home Blood Pressure Monitoring 2023 Treatment Timeline for Medical Study. Trial Name: NCT05481892 — N/A

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Are participants in this trial required to be over the age of 35?

"According to the inclusion criteria, people aged 18-85 are eligible for this clinical trial. There are currently 56 trials underway for patients that are under 18 and 692 trials for those over 65."

Answered by AI

Are people currently signing up for this experiment?

"No, this particular trial is not looking for any more patients at the moment. According to the listing on clinicaltrials.gov, the study was originally posted on 1/1/2023 and was last updated on 11/3/2022. There are currently 783 other trials that are actively recruiting patients."

Answered by AI

Who would be an ideal candidate for this clinical trial?

"Eligibility criteria for this clinical trial includes hypertension and being between 18-85 years old. Up to 540 people can be enrolled in the study."

Answered by AI

Who else is applying?

What state do they live in?
California
How old are they?
18 - 65
What site did they apply to?
Zuckerberg San Francisco General Hospital/University of California, San Francisco
What portion of applicants met pre-screening criteria?
Did not meet criteria
Recent research and studies
clinicaltrials.govStudy
Remote Monitoring for Equity in Advancing Control of Hypertension
2023. "Remote Monitoring for Equity in Advancing Control of Hypertension". ClinicalTrials.gov. https://clinicaltrials.gov/ct2/show/NCT05481892.
~331 spots leftby Dec 2025
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top